# Teva Pharmaceutical Industries

Teva Pharmaceutical Industries is a Corporate Investor based in Petach Tikva, Israel.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Petach Tikva, Israel
- **Region:** Middle East
- **Address:** 124 Dvora HaNevi'a St, Petah Tikva, Israel
- **Founded:** 1901
- **Assets under management:** Undisclosed
- **Website:** tevapharm.com
- **LinkedIn:** https://www.linkedin.com/company/teva-pharmaceuticals
- **Wikidata:** Q898750

## Regulatory record

- **Reports private funds:** No

## About

Learn how the Teva Pharmaceutical Company pushes the boundaries of scientific innovation and delivers quality medication for millions of patients every day.

## Sectors

- Pharma & Biotech
- Digital Health
- Healthcare Services

## Offices

- Parsippany, NJ, United States
- Jerusalem, Israel
- Dupnitsa, Bulgaria
- Markham, Ontario, Canada

## People

- Amir Elstein — Director

## Questions

### Who runs investment decisions at Teva Pharmaceutical Industries?

Teva does not have a standalone investment team like a corporate venture capital unit. Strategic investments, licensing deals, and co-development partnerships are driven by the business development and corporate strategy functions under the CEO. Board-level oversight includes Amir Elstein, representing the founding family, and Elliott Investment Management appointees as of 2025.

### How does Teva source its biotech co-development deals?

Teva sources partnerships through its internal R&D scouting teams, industry conferences, and its deep relationships with generics and specialty pharmacy supply chains. Partnerships like the Sanofi duvakitug deal and the Blackstone Life Sciences co-funding arrangement reflect a mix of late-stage pipeline licensing and structured manufacturing collaboration, rather than early-stage venture bets.

### Does Teva participate in fund commitments or only direct deals?

Teva operates almost entirely through direct balance-sheet investments — co-development agreements, licensing pacts, and manufacturing joint ventures. The firm does not publicly disclose commitments to third-party venture funds, distinguishing its investment posture from that of pharma companies that maintain dedicated corporate VC arms.

### How is Teva related to the Elstein family?

The Elstein family provided foundational capital when Teva was established in 1901 and has maintained board representation across multiple generations. Amir Elstein currently serves as a director, preserving a direct lineage connection to the firm's founding ownership structure. The family's ongoing role is exercised through board governance rather than executive management.

### What is Teva's known posture on co-investments alongside external GPs?

Teva does not publicize a co-investment program in the institutional LP sense. Its collaborative model involves partnering with financial sponsors like Blackstone Life Sciences on specific development-stage assets. These are structured as bilateral deals tied to product economics rather than commingled fund vehicles.

## Related profiles

- [Teton Crest Wealth Planning](https://altss.com/profile/teton-crest-wealth-planning)
- [Tevis Investment Management](https://altss.com/profile/tevis-investment-management)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/teva-pharmaceutical-industries

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology